Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
Clinical trial NCT04502069 · WITHDRAWN
Trial details
- NCT number
- NCT04502069
- Sponsor
- RedHill Biopharma Limited
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.